Time specifically noted its potential to revolutionize obesity management by removing the burdensome dosing rules associated with other GLP-1 therapies, possibly improving adherence among patients
The study also did not find meaningful increases in the risk of: Low birth weight High birth weight Major congenital anomalies Researchers cautioned that estimates for some rarer outcomes were less precise, meaning additional research is still needed
Additional Phase 3 readouts expected in 2026
Ingredients of Vesco Pharma Glutathione and Vitamin C Capsules Combo Coenzyme Q10: 100 mg Selenium (100mg): Enhances your skin's defense system, combats inflammation, and fortifies your skin against external stressors
The delivery model functions entirely online, without in-person visits or physical clinic locations
Since clinical trial registries rely on sponsor-reported information, analyses were conducted using only available data